LAST UPDATED
May 14, 2026
Clinicaltrials.gov ID
EudraCT ID
CTSID
OVERVIEW
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
PROTOCOL SUMMARY
The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of Kite study drugs, axicabtagene ciloleucel, brexucabtagene autoleucel, KITE-363, KITE-753, KITE-197, and anitocabtagene autoleucel in participants of Kite-sponsored interventional studies.
View moreParticipation requirements
Age
N/A
Sex
All
Healthy Volunteers
No
Age
N/A
Sex
All
Healthy Volunteers
No
Study details
Medical Condition
Solid and Hematological Malignancies
Gender
N/A
Date
December 2021 - December 2040
Study Type
Observational
Study Phase
Product
Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, Anitocabtagene autleucel, KITE-753, KITE-197, KITE-363
Eligibility information
Inclusion criteria
- The individual must have received an infusion of gene-modified cells in a completed Kite-sponsored parent study, has not withdrawn full consent, and has discontinued or completed the post-treatment follow-up period in the parent study, as applicable
- The individual must understand and voluntarily sign an Informed Consent Form (ICF) or an Informed Assent Form prior to any study-related assessments or procedures being conducted
- In the investigator's judgment, the individual is willing and able to complete the protocol-required follow-up schedule and comply with the study requirements for participation
Locations
Locations (90)
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States, 85234
UC San Diego Moores Cancer Center
La Jolla, California, United States, 92093
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
University of California Los Angeles
Los Angeles, California, United States, 90095
Children's Hospital of Orange County
Orange, California, United States, 92868
University of California Davis Comprehensive Cancer Center
Sacramento, California, United States, 95817
University of California, San Francisco Medical Center
San Francisco, California, United States, 94143
Colorado Blood Cancer Institute
Denver, Colorado, United States, 80218
Georgetown University Medical Center
Washington D.C., District of Columbia, United States, 20007
Sylvester Comprehensive Cancer Centre
Miami, Florida, United States, 33136
Ann& Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611
University of Chicago Medical Center Clinical Laboratories
Chicago, Illinois, United States, 60637
Loyola University Medical Center
Maywood, Illinois, United States, 60153
The University of Kansas Cancer Center Westwood
Westwood, Kansas, United States, 66205
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States, 21201
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Karmanos Cancer Center Institute
Detroit, Michigan, United States, 48201
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263
Ichann School of Medicine at Mount Sinai
New York, New York, United States, 10029
Columbia University Medical Center
New York, New York, United States, 10032
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
University of Rochester Medical Center
Rochester, New York, United States, 14642
DUHS-Duke Blood Cancer Center
Durham, North Carolina, United States, 27710
James Cancer Hospital and Solove Research Institute
Columbus, Ohio, United States, 43220
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232
Prisma Health Cancer Institute
Greenville, South Carolina, United States, 29615
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sarah Cannon-Methodist Healthcare System - San Antonio
San Antonio, Texas, United States, 78229
Intermountain LDS Hospita;/Blood and Marrow Transplant/ Acute Leukemia Program
Salt Lake City, Utah, United States, 84143
University of Virginia Health System
Charlottesville, Virginia, United States, 22908
Virginia Commonwealth University
Richmond, Virginia, United States, 23219
Fred Hutchinson Cancer Center
Seattle, Washington, United States, 98109
Medizinische Universitat Innsbruck, Innere Medizin V - Hamatologie und Onkologie
Innsbruck, Austria, 6020
Princess Margaret Cancer Center - University Health Network
Toronto, Canada, M5G 2C4
Centre Hospitalier Regional Universitaire de Lille
Lille, France, 59037
Johannes Gutenberg University Hospital-University Mainz
Mainz, Germany, 55101
LMU Klinikum der Universitat Munchen,Med. Klinik und Poliklinik III
München, Germany, 81377
Universitatsklinikum Wurzburg, Med. Klinik und Poliklinik II, Zentrum lnnere Medizin
Würzburg, Germany, 97080
Amsterdam Universitair Medische Centra (UMC)
Amsterdam, Netherlands, 1100
Erasmus University Medical Centre (MC)
Rotterdam, Netherlands, 3011PL
Istituto Oncologico Della Svizzera Italiana (IOSI)
Bellinzona, Switzerland, 6500
The Royal Marsden NHS Foundation Hospital
London, United Kingdom, SW10 9NH
Join Gilead Trial Connect and help advance clinical research. Your participation is key to developing future treatments.
Share Trial